More about NATCO Pharma Limited

Technicals for NATCO Pharma Limited

The STOCHASTIC is showing a neutral stance, with no definitive indication of...

NATCOPHARM's current ratio being 5.586 suggests that it has more than enough...

The list of all important regulatory filings for NATCO Pharma Limited which...

The article analyzes recent trends in the yield and convenience of U.S....

An analysis of WFH Research’s monthly time-series data on remote work trends,...

Analysis of the St. Louis Fed’s view that economic education strengthens monetary...

Last Updated:

2025-10-17 21:26

Published	Title	Summary
2025-07-25 17:06:34	Acquisition-XBRL	NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition...
NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-01-30 16:38:38	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend.
2024-08-12 14:07:44	Dividend	Natco Pharma Limited has informed the Exchange that Board of...
Natco Pharma Limited has informed the Exchange that Board of Directors at its meeting held on August 12, 2024, considered Unaudited Financial Results for the quarter ended 30th June, 2024 and declared Interim Dividend of Rs. 3.00 per equity share along with other Agenda Items
2024-07-26 16:06:49	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Dividend.